Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 11/20 | 0.44 |
| ▸ | MMP1 | P03956 | 6/20 | 0.44 |
| ▸ | MMP3 | P08254 | 6/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MMP7 | P09237 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17027839 | 1.00 | CSNK1E (0.58) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL10521595 | 1.00 | CSNK1E (0.58) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL10965122 | 1.00 | CSNK1E (0.58) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL9280760 | 1.00 | CSNK1E (0.58) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL10519442 | 1.00 | CSNK1E (0.58) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL9665073 | 1.00 | CSNK1E (0.58) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL20164916 | 0.98 | CSNK1E (0.55) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL111455 | 0.98 | CSNK1E (0.55) | CSNK1ELMNATRPA1CNR2MMP2 | |
| SCHEMBL8093074 | 0.89 | CSNK1E (0.60) | CSNK1ECNR2MMP2MMP1MMP3 | |
| SCHEMBL22806767 | 0.89 | CSNK1E (0.60) | CSNK1ECNR2MMP2MMP1MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4648984-A | 2-BENZYL-1-ALKANOL POLYGLYCOL ETHERS; WETTING AGENTS, DISPERSANTS, EMULSIFIERS AND DETERGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-03-10 | — | — | US | claimed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. | 2016-06-30 | — | — | US | disclosed |
| WO-2015126462-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA, INC. (US) | 2015-08-27 | — | — | WO | disclosed |
| EP-0212610-B1 | USE OF 2-ALKYLALKANOL-1-POLYGLYCOL ETHER | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-01-22 | — | — | EP | disclosed |
| EP-0224523-B1 | PARTIAL ESTHERS OF 2-BENZYLALKANOLS-(1) AND 2-BENZYLALKANOL-1-POLYGLYCOL ETHERS AS WELL AS PRODUCTION PROCESS THEREOF | Henkel Kommanditgesellschaft auf Aktien (DE) | 1989-03-01 | — | — | EP | disclosed |
| US-4772670-A | Emulsion polymerization compositions containing 2-alkyl-1-alkanol polyglycolethers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1988-09-20 | — | — | US | disclosed |
| EP-0233193-A1 | 2-BENZYLALCANOL-1-POLYGLYCOL ETHER AND PRODUCTION PROCESS THEREOF | Henkel Kommanditgesellschaft auf Aktien (DE) | 1987-08-26 | — | — | EP | disclosed |
| EP-0224523-A1 | PARTIAL ESTHERS OF 2-BENZYLALKANOLS-(1) AND 2-BENZYLALKANOL-1-POLYGLYCOL ETHERS AS WELL AS PRODUCTION PROCESS THEREOF. | HENKEL KGAA (DE) | 1987-06-10 | — | — | EP | disclosed |
| US-4648984-A | 2-BENZYL-1-ALKANOL POLYGLYCOL ETHERS; WETTING AGENTS, DISPERSANTS, EMULSIFIERS AND DETERGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-03-10 | — | — | US | disclosed |
| EP-0212610-A2 | Use of 2-alkylalkanol-1-polyglycol ether | Henkel Kommanditgesellschaft auf Aktien (DE) | 1987-03-04 | — | — | EP | disclosed |
| WO-1986007356-A1 | PARTIAL ESTHERS OF 2-BENZYLALKANOLS-(1) AND 2-BENZYLALKANOL-1-POLYGLYCOL ETHERS AS WELL AS PRODUCTION PROCESS THEREOF | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1986-12-18 | — | — | WO | disclosed |
| WO-1986007352-A1 | 2-BENZYLALCANOL-1-POLYGLYCOL ETHER AND PRODUCTION PROCESS THEREOF | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1986-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160186094-A1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | SMURF2, EPHX2, SMURF1 | CSNK1E 4831/4885LMNA 1872/4885TRPA1 1614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.